101 related articles for article (PubMed ID: 9488641)
1. Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen.
Carella AM; Lerma E; Celesti L; Dejana A; Panagiotis Z; Corsetti MT; Frassoni F
Br J Haematol; 1998 Feb; 100(2):445-8. PubMed ID: 9488641
[TBL] [Abstract][Full Text] [Related]
2. Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha.
Carella AM; Simonsson B; Link H; Lennard A; Boogaerts M; Gorin NC; Tomas-Martinez JF; Dabouz-Harrouche F; Gautier L; Badri N
Br J Haematol; 1998 Apr; 101(1):111-8. PubMed ID: 9576191
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.
Deininger M; Pönisch W; Krahl R; Leiblein S; Edel E; Lange T; Fiedler F; Freund M; Franke A; Pasold R; von Grünhagen U; Herold M; Dölken G; Hoffmann FA; Uhle R; Schultze W; Steglich J; Schwarzer A; Richter P; Winkelmann C; Kettner E; Dachselt K; Subert R; Schwalbe E; Doepper J; Helbig W; Niederwieser D;
Bone Marrow Transplant; 2001 Jun; 27(11):1125-32. PubMed ID: 11551022
[TBL] [Abstract][Full Text] [Related]
4. Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.
Mele A; Leopardi G; Sparaventi G; Nicolini G; D'Adamo F; Guiducci B; Barulli S; Malerba L; Stramigioli S; Talevi N; Politi P; Isidori A; Malagola M; Piccaluga P; Visani G
Eur J Haematol; 2005 Apr; 74(4):277-81. PubMed ID: 15777338
[TBL] [Abstract][Full Text] [Related]
5. Mini-ICE regimen allows mobilization of peripheral blood progenitor cells in a patient with chronic myelogenous leukemia failing the ICE protocol.
Salar A; Sureda A; Menéndez B; Sierra J
Haematologica; 2000 Mar; 85(3):326-7. PubMed ID: 10702830
[No Abstract] [Full Text] [Related]
6. In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia.
Carella AM; Dejana A; Lerma E; Podestà M; Benvenuto F; Chimirri F; Parodi C; Sessarego M; Prencipe E; Frassoni F
Br J Haematol; 1996 Oct; 95(1):127-30. PubMed ID: 8857949
[TBL] [Abstract][Full Text] [Related]
7. Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia.
Carella AM; Frassoni F; Podestá M; Pungolino E; Pollicardo N; Ferrero R; Soracco M
J Hematother; 1994; 3(3):199-202. PubMed ID: 7530135
[TBL] [Abstract][Full Text] [Related]
8. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González JR; Amill B; Larriba I; Blanco A; Martín-Henao GA; Sierra J; Grañena A
Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
[TBL] [Abstract][Full Text] [Related]
9. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Olsson-Strömberg U; Höglund M; Björkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Löfvenberg E; Malm C; Nilsson PG; Paul C; Rödjer S; Stenke L; Tidefeldt U; Turesson I; Uden AM; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Leuk Lymphoma; 2006 Sep; 47(9):1768-73. PubMed ID: 17064986
[TBL] [Abstract][Full Text] [Related]
10. More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.
Höglund M; Brune M; Sallerfors B; Ahlgren T; Billström R; Hedenus M; Markevärn B; Nilsson B; Simonsson B; Stockelberg D; Wahlin A
Bone Marrow Transplant; 2003 Dec; 32(12):1119-24. PubMed ID: 14647265
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
Boqué C; Petit J; Sarrá J; Cancelas JA; Muñoz J; Español JI; de la Banda E; Aventin A; Berlanga J; Ferrá C; Amill B; Torrico C; Azqueta C; Llucià M; García J; Grañena A
Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840
[TBL] [Abstract][Full Text] [Related]
12. Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied.
Fischer T; Neubauer A; Mohm J; Huhn D; Busemann C; Link H; Arseniev L; Büssing B; Novotny J; Ganser A; Duyster J; Bunjes D; Westermeier T; Flohr T; Desprès D; Gamm H; Decker J; Derigs G; Aulitzky W; Huber C
Ann Hematol; 1998; 77(1-2):21-6. PubMed ID: 9760148
[TBL] [Abstract][Full Text] [Related]
13. Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia with different clinical stages.
Gopcsa L; Barta A; Banyai A; Foldi J; Kalasz L; Pajor L; Gidali J; Regeczy N; Paloczi K
Acta Haematol; 2001; 106(3):100-5. PubMed ID: 11713374
[TBL] [Abstract][Full Text] [Related]
14. Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine A.
Carella AM; Gaozza E; Raffo MR; Carlier P; Frassoni F; Valbonesi M; Lercari G; Sessarego M; Defferrari R; Guerrasio A
Leukemia; 1991 Jun; 5(6):517-21. PubMed ID: 1676080
[TBL] [Abstract][Full Text] [Related]
15. Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon.
Reiffers J; Taylor K; Gluckman E; Gorin NC; Mahon FX; Micléa JM; Destrée D; Gautier L
Br J Haematol; 1998 Aug; 102(3):639-46. PubMed ID: 9722288
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.
Aulitzky WE; Neubauer A; Kolbe K; Schneller F; Busemann C; Schleiermacher E; Peschel C; Siegert W; Huber C; Huhn D
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S67-9. PubMed ID: 8769707
[TBL] [Abstract][Full Text] [Related]
17. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
[TBL] [Abstract][Full Text] [Related]
18. Mobilization and transplantation of Philadelphia chromosome-negative peripheral blood progenitor cells in patients with CML.
Waller CF; Heinzinger M; Rosenstiel A; Lange W
Br J Haematol; 1998 Oct; 103(1):227-34. PubMed ID: 9792314
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Niewint AW; Ossenkoppele GJ
Bone Marrow Transplant; 1997 Nov; 20(10):835-42. PubMed ID: 9404923
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.
Balduzzi A; Perseghin P; Dassi M; Bonanomi S; Rovelli A; Gaipa G; Biondi A; Uderzo C
Bone Marrow Transplant; 2002 Oct; 30(7):413-6. PubMed ID: 12368951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
